Tag: Alzheimer Drug

Clinical Trials, Research and Development

Large Clinical Trial Supports Alzheimer Drug Full Approval

July 11, 2023

Via: Biopharm International

FDA recently granted full, or traditional, approval to Eisai Pharmaceutical’s Alzheimer’s treatment Leqembi, converting an earlier conditional approval status with further data from a multi-regional study of nearly 1800 patients. Results indicated that the drug slows the rate of cognitive […]